Evidence map›Paper›PMID 40474741›Full record

ArticleJournal of comparative effectiveness research2025

Expert perspectives on the use of safinamide for Parkinson's disease in Portugal: insights from a Portuguese Delphi Consensus.

Ana Margarida Rodrigues, Cristina Costa, Miguel Gago, Miguel Grunho, Leonor Correia Guedes, Ana Morgadinho, Maria José Rosas, Rita Simões, Ana Graça Velon

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of comparative effectiveness research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana Margarida RodriguesCNS - Campus Neurológico (Braga), 4710-452 Braga, Portugal.
Cristina CostaCNS - Campus Neurológico (Braga), 4710-452 Braga, Portugal.
Miguel GagoCNS - Campus Neurológico (Braga), 4710-452 Braga, Portugal.
Miguel GrunhoDepartment of Neurology, Hospital Garcia de Orta, Unidade Local de Saúde de Almada-Seixal, 2805-267 Almada, Portugal.
Leonor Correia GuedesCNS - Campus Neurológico (Torres Vedras), 2560-280 Torres Vedras, Portugal.
Ana MorgadinhoDepartment of Neurology, Hospital Hospital da Luz Coimbra, 3020-479 Coimbra, Portugal.
Maria José RosasDepartment of Neurology, Hospital de São João, Unidade Local de Saúde de São João, 4200-319 Porto, Portugal.
Rita SimõesCNS - Campus Neurológico (Torres Vedras), 2560-280 Torres Vedras, Portugal.
Ana Graça VelonDepartment of Neurology, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, 5000-508 Vila Real, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlanineAntiparkinson AgentsBenzylaminesParkinson DiseaseDelphi TechniqueFemaleFocus GroupsHumansMaleNeurologistsPortugalQuality of LifeSurveys and QuestionnairesAlanineAntiparkinson AgentsBenzylaminessafinamideDelphidyskinesiaefficacyfluctuationsmotor symptomsnonmotor symptomsParkinson’s diseasePortugalsafetysafinamide

Identifiers

PMID40474741
PMCPMC12224116

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.